Australia's Monash University and The Alfred have announced the launch of The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) to tackle major challenges in cancer immunotherapy by better understanding how a patient’s immune system responds to treatment.
Headquartered at The Alfred’s Paula Fox Melanoma and Cancer Centre and co-located with Monash University’s Alfred campus, research at the CDIO will conduct real-time monitoring of a patient's response to immunotherapy to improve detection of early anti-tumour benefits and side-effects.
The CDIO is part of Monash University’s new Department of Cancer Medicine, which will advance cancer research and clinical trials in Melbourne’s south-east and regional Victoria.
Foundation and the National Imaging Facility, leverages cutting edge equipment already in place at The Alfred, including the new $24 million Quadra PET/CT scanner, one of the most advanced scanners of its kind in the world.
The total-body scanner enables earlier detection of very small cancers, faster and safer scans, and real-time assessment of treatment progress, enabling earlier diagnosis, and safer and more tailored treatments for patients, as well as enhanced research and clinical trials capacity.
